Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LNCRNA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | LNCRNA |
| Key Genes/Proteins | ABCA7, Actin, Akt, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID |
| Related Diseases | Als, ALS, Alzheimer, Amyotrophic Lateral Sclerosis |
| Related Pathways | Amyloid, Apoptosis |
graph TD
LNCRNA["LNCRNA"]
style LNCRNA fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
LNCRNA -->|"involved_in"| Cancer_Initiation["Cancer Initiation"]
LNCRNA -->|"involved_in"| Cancer_Development["Cancer Development"]
LNCRNA -->|"regulates"| Chromatin_Organization["Chromatin Organization"]
LNCRNA -->|"regulates"| Transcriptional_Regulation["Transcriptional Regulation"]
LNCRNA -->|"regulates"| Post_transcriptional_Regulatio["Post-transcriptional Regulation"]
LNCRNA -->|"contributes to"| Tumor_Initiation["Tumor Initiation"]
LNCRNA -->|"contributes to"| Tumor_Growth["Tumor Growth"]
LNCRNA -->|"contributes to"| Metastasis["Metastasis"]
INFLAMMATION([INFLAMMATION]) -->|"activates"| LNCRNA
GAP43([GAP43]) -->|"activates"| LNCRNA
RNA([RNA]) -->|"activates"| LNCRNA
AND([AND]) -->|"activates"| LNCRNA
LOC100911717([LOC100911717]) -->|"activates"| LNCRNA
DNA([DNA]) -->|"regulates"| LNCRNA
MIR31HG([MIR31HG]) -->|"activates"| LNCRNA
HUNTINGTON([HUNTINGTON]) -->|"activates"| LNCRNA| Target | Relation | Type | Str |
|---|---|---|---|
| Programmed Cell Death | regulates | process | 0.95 |
| Cancer Development | involved_in | process | 0.90 |
| Cancer Initiation | involved_in | process | 0.90 |
| Post-transcriptional Regulation | regulates | process | 0.85 |
| Tumor Initiation | contributes_to | process | 0.85 |
| Tumor Growth | contributes_to | process | 0.85 |
| Cancer Initiation | involved_in | disease | 0.85 |
| Chromatin Organization | regulates | process | 0.85 |
| Transcriptional Regulation | regulates | process | 0.85 |
| Chromatin Organization | regulates | process | 0.85 |
| Transcriptional Regulation | regulates | process | 0.85 |
| Neurodegeneration | biomarker_for | process | 0.85 |
| PARKINSON'S DISEASE | biomarker_for | disease | 0.85 |
| ALZHEIMER'S DISEASE | biomarker_for | disease | 0.85 |
| AUTOPHAGY | regulates | process | 0.85 |
| APOPTOSIS | regulates | process | 0.85 |
| Metastasis | contributes_to | process | 0.85 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.80 |
| Alzheimer'S Disease | modulates | disease | 0.80 |
| Huntington's Disease | modulates | disease | 0.80 |
| Rna | interacts_with | compound | 0.80 |
| PROTEIN | interacts_with | protein | 0.80 |
| Aging | biomarker_for | process | 0.80 |
| Dna | interacts_with | compound | 0.80 |
| Cancer Metastasis | involved_in | disease | 0.80 |
| Huntington's Disease | therapeutic_target | disease | 0.80 |
| Amyotrophic Lateral Sclerosis | modulates | disease | 0.80 |
| Cancer Diagnosis | biomarker_for | process | 0.75 |
| Cancer Therapy | involved_in | process | 0.70 |
| Als | expressed_in | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Ferroptosis | activates | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Cardiovascular | regulates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Pyroptosis | associated_with | disease | 0.65 |
| Ferroptosis | associated_with | disease | 0.65 |
| Necroptosis | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MYC | associated_with | gene | 0.60 |
| TRAF6 | inhibits | gene | 0.60 |
| HDAC3 | inhibits | gene | 0.60 |
| SLC16A1 | interacts_with | gene | 0.60 |
| C-MYC | associated_with | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| MIR31HG | activates | gene | 0.60 |
| PYROPTOSIS | associated_with | gene | 0.60 |
| P2RX7 | expressed_in | gene | 0.60 |
| HMOX1 | expressed_in | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| MIRNAS | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| FERROPTOSIS | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| NEUROTOXICITY | activates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| SRPK1 | activates | gene | 0.60 |
| FOSL2 | activates | gene | 0.60 |
| GSH | activates | gene | 0.60 |
| NAMPT | activates | gene | 0.60 |
| GBM | interacts_with | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| MIR-1269 | interacts_with | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| SLC16A1-AS1 | interacts_with | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| ABCA7 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| CD2AP | activates | gene | 0.60 |
| EPHA1 | activates | gene | 0.60 |
| CLU | activates | gene | 0.60 |
| BIN1 | activates | gene | 0.60 |
| CASS4 | activates | gene | 0.60 |
| CD33 | activates | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| P16 | regulates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| RAF | activates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| MYC | activates | gene | 0.60 |
| C-MYC | activates | gene | 0.60 |
| CDKN2B-AS1 | activates | gene | 0.60 |
| CDKN2B | activates | gene | 0.60 |
| HUNTINGTIN | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning LNCRNA in their description or question text
Score: 0.640 · molecular neurobiology · 2026-04-25
The most likely explanation is a two-factor recognition mechanism: a canonical miRNA seed-complementary site in lncRNA-0
Score: 0.540 · molecular neurobiology · 2026-04-25
lncRNA-0021 may contain a pre-folded structural element that lowers the entropic cost of binding and presents the miR-63
Score: 0.536 · molecular neurobiology · 2026-04-17
## Mechanistic Overview Gamma-Entrained PV Interneurons Enable p-tau217-Guided Precision Dosing of lncRNA Therapeutics i
Score: 0.536 · molecular neurobiology · 2026-04-20
## Mechanistic Overview Cerebrospinal NFL-Triggered Liposome Dosing Maximizes lncRNA-0021 Therapeutic Window in AD start
Score: 0.536 · molecular neurobiology · 2026-04-20
## Mechanistic Overview Gamma-Entrained PV Interneuron Networks Enable Precision p-tau217-Guided lncRNA Exosome Therapy
Score: 0.536 · molecular neurobiology · 2026-04-17
## Mechanistic Overview Cerebrospinal Fluid p-tau217-Guided Astrocyte-Derived Extracellular Vesicle Delivery of lncRNA-0
Score: 0.489 · molecular biology · 2026-04-21
## Mechanistic Overview Structured Intronic Scaffold Regions in Enhancer-dilncRNAs Enable Cell-Type Selective Targeting
Score: 0.480 · molecular neurobiology · 2026-04-25
An auxiliary protein, such as TDP-43, FUS, or an hnRNP family member, may bind lncRNA-0021 and/or mmu-miR-6361 to increa
Score: 0.466 · molecular neurobiology · 2026-04-21
## Mechanistic Overview Alpha-Beta Oscillation Coupling Enhances lncRNA-9969-Mediated Autophagy Through SST Interneuron-
Score: 0.461 · molecular neurobiology · 2026-04-21
## Mechanistic Overview Gamma-Entrained PV Interneurons Enable Precision p-tau217-Guided lncRNA Exosome Therapy in Early
Score: 0.461 · molecular neurobiology · 2026-04-21
## Mechanistic Overview CSF Neurofilament Light Chain-Guided Astrocyte-Derived Extracellular Vesicle Delivery of lncRNA-
Score: 0.460 · molecular neurobiology · 2026-04-21
## Mechanistic Overview CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome Dosing Maximizes lncRNA-0021 Therape
Score: 0.451 · molecular neurobiology · 2026-04-17
## Mechanistic Overview Alpha-Beta Oscillation Entrainment Enhances lncRNA-9969-Mediated Mitochondrial Biogenesis Throug
Score: 0.451 · molecular neurobiology · 2026-04-20
## Mechanistic Overview Alpha-Theta Oscillation Modulation Enhances lncRNA-9969-Mediated Autophagy Through SST Interneur
Score: 0.438 · molecular neurobiology · 2026-04-21
## Mechanistic Overview Theta-Gamma Coupling Modulates lncRNA-9969-Mediated Mitochondrial Biogenesis Through SST Interne